Sponsor

Bellerophon

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Bellerophon appears in 6 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials6
Recruiting shown0
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

6 shown
A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or SarcoidosisNCT03727451 · lead sponsor · 2019-01-30
COMPLETED
A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary FibrosisNCT05747508 · lead sponsor · 2017-12-29
UNKNOWN
Effect iNO on Functional Respiratory Imaging in Subjects With WHO Group 3 Pulmonary Hypertension With COPD on OxygenNCT03135860 · lead sponsor · 2016-10-01
TERMINATED
3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPFNCT02267655 · lead sponsor · 2015-05-01
COMPLETED
Expanded Access for Patients With Pulmonary Hypertension Associated With Pulmonary FibrosisNCT05356052 · lead sponsor
AVAILABLE
Inhaled NO in IPF and COPD During 6 Minute Walk TestNCT03873298 · collaborator · 2019-03-04
UNKNOWN

Sponsor roles

lead sponsor5
collaborator1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.